Jennison Associates
EIGR

Jennison Associates’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Jennison Associates’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-42,133
Closed -$15.2M – 733
2018
Q3 		$15.2M Buy
42,133
+250
+0.6% +$85.5K 0.01% 431
2018
Q2 		$15.3M Buy
41,883
+20,212
+93% +$7.2M 0.02% 435
2018
Q1 		$6.4M Buy
21,671
+1,528
+8% +$451K 0.01% 481
2017
Q4 		$8.43M Buy
+20,143
New +$7.2M 0.01% 473

Other funds holding EIGR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return